Artwork

Content provided by Becker's Healthcare. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Becker's Healthcare or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Paige Twenter, Assistant Editor at Becker's Healthcare

6:37
 
Share
 

Manage episode 423451864 series 2826750
Content provided by Becker's Healthcare. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Becker's Healthcare or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This episode features Paige Twenter, Assistant Editor at Becker's Healthcare. Here, she discusses recent developments in the healthcare sector. Twenter highlights new research on the safety and risks associated with GLP-1 drugs, particularly Ozempic, and its potential benefits for chronic kidney disease. She also examines legislative changes affecting the 340B drug pricing program and their implications for hospitals and drug manufacturers, emphasizing the growing tension between these stakeholders.

  continue reading

451 episodes

Artwork
iconShare
 
Manage episode 423451864 series 2826750
Content provided by Becker's Healthcare. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Becker's Healthcare or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This episode features Paige Twenter, Assistant Editor at Becker's Healthcare. Here, she discusses recent developments in the healthcare sector. Twenter highlights new research on the safety and risks associated with GLP-1 drugs, particularly Ozempic, and its potential benefits for chronic kidney disease. She also examines legislative changes affecting the 340B drug pricing program and their implications for hospitals and drug manufacturers, emphasizing the growing tension between these stakeholders.

  continue reading

451 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide